SYNERGETIC PHARMACEUTICAL COMPOSITION FOR PROPHYLAXIS AND TREATMENT OF DIABETES MELLITUS
FIELD: medicine, endocrinology, pharmacy. ^ SUBSTANCE: invention relates to drugs and concerns a synergetic pharmaceutical composition comprising the following components: (a) the first pharmaceutical composition containing antidiabetic active component chosen from group consisting of insulin, metfo...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English Russian |
Published |
10.12.2007
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | FIELD: medicine, endocrinology, pharmacy. ^ SUBSTANCE: invention relates to drugs and concerns a synergetic pharmaceutical composition comprising the following components: (a) the first pharmaceutical composition containing antidiabetic active component chosen from group consisting of insulin, metformin and glyburide, or antihyperlipidemic active component chosen from group consisting of lovastatin and simvastatin, and one or more standard carriers, and (b) the second pharmaceutical composition comprising O-(3-piperidino-2-hydroxy-1-propyl)-nicotinamidoxime or its pharmaceutically acceptable salt and one or more standard carriers. Proposed pharmaceutical composition is useful for prophylaxis or treatment of insulin-resistance, metabolic X-syndrome or diabetes mellitus of type 2. The proposed composition possesses high effectiveness in lower doses that results to reducing toxicity treatment. ^ EFFECT: improved and valuable medicinal properties of composition. ^ 3 cl, 5 tbl |
---|---|
AbstractList | FIELD: medicine, endocrinology, pharmacy. ^ SUBSTANCE: invention relates to drugs and concerns a synergetic pharmaceutical composition comprising the following components: (a) the first pharmaceutical composition containing antidiabetic active component chosen from group consisting of insulin, metformin and glyburide, or antihyperlipidemic active component chosen from group consisting of lovastatin and simvastatin, and one or more standard carriers, and (b) the second pharmaceutical composition comprising O-(3-piperidino-2-hydroxy-1-propyl)-nicotinamidoxime or its pharmaceutically acceptable salt and one or more standard carriers. Proposed pharmaceutical composition is useful for prophylaxis or treatment of insulin-resistance, metabolic X-syndrome or diabetes mellitus of type 2. The proposed composition possesses high effectiveness in lower doses that results to reducing toxicity treatment. ^ EFFECT: improved and valuable medicinal properties of composition. ^ 3 cl, 5 tbl |
Author | LITERATI NAD' PETER SIL'VASHI ZOL'TAN RABLOTSKI D'ERDI |
Author_xml | – fullname: SIL'VASHI ZOL'TAN – fullname: LITERATI NAD' PETER – fullname: RABLOTSKI D'ERDI |
BookMark | eNqNyjsKg0AQgOEtkiKvO8wFAlGLYDlZx7iwL3ZH0EokbKqggrk_SZEDpPr54N-LzTRPaSe62FsKd2IlwTcYDEpqv0AN0hnvomLlLNQugA_ON73GTkVAWwEHQjZkGVwNlcIbMUUwpLXiNh7F9jm-1nT69SCgJpbNOS3zkNZlfKQpvYfQ5kWWlZerzIs_lg8fyzNH |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | СИНЕРГИЧНЫЙ ФАРМАЦЕВТИЧЕСКИЙ СОСТАВ ДЛЯ ПРОФИЛАКТИКИ ИЛИ ЛЕЧЕНИЯ ДИАБЕТА |
ExternalDocumentID | RU2311907C2 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_RU2311907C23 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 13:09:10 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English Russian |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_RU2311907C23 |
Notes | Application Number: RU20040105149 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20071210&DB=EPODOC&CC=RU&NR=2311907C2 |
ParticipantIDs | epo_espacenet_RU2311907C2 |
PublicationCentury | 2000 |
PublicationDate | 20071210 |
PublicationDateYYYYMMDD | 2007-12-10 |
PublicationDate_xml | – month: 12 year: 2007 text: 20071210 day: 10 |
PublicationDecade | 2000 |
PublicationYear | 2007 |
RelatedCompanies | N-DZHIN RESERCH LABORATORIZ INK |
RelatedCompanies_xml | – name: N-DZHIN RESERCH LABORATORIZ INK |
Score | 2.6896915 |
Snippet | FIELD: medicine, endocrinology, pharmacy. ^ SUBSTANCE: invention relates to drugs and concerns a synergetic pharmaceutical composition comprising the following... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | SYNERGETIC PHARMACEUTICAL COMPOSITION FOR PROPHYLAXIS AND TREATMENT OF DIABETES MELLITUS |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20071210&DB=EPODOC&locale=&CC=RU&NR=2311907C2 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NS8MwFA9DRb3pVJxf5CC9FV2btvZQpEtTW7EfpKl0p9FuHeyyja3Df9-Xsk0vegsJPJIHv_eVvF8QetRsAqDRiUrqulKJRWzVnk511bCnhlkbdqVNZKNwFJtBTt4Lo-ig2a4XpuUJ_WrJEQFRY8B709rr5U8Ry2vfVq6fqhlMLV594XjKLju2JB-W4g0cliZeQhVKHZ4rMXcgjAHXZ1Gw1ocQRVsSDOxzIJtSlr89in-GjlIQNm_OUWe16aITuvt4rYuOo-19Nwy30FtfoCIbxoy_MRFSnAYuj1zKciHZDDBNojTJQllswpDU4ZQnaTD8cIsww27sYcGZKyRpP0587IXugAmW4YhBHi_y7BJhnwkaqLDF0V4dI57vD6NfoYP5Yl5fI2yUWlmC1p_JxATHNClL_cUcy6KvOe73TbuHen-Kufln7RadtuXMvgYW-w4dNKtNfQ9-uKkeWg1-A0H6hhk |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT8IwFG-IGvGmqBE_ezC7Lco-3WExo-vclH2k68w4kQ1GwgUIjPjv-7oAetFb0yYv7Ut-76t9vyL0qFgagEbVZK2qSlkzNUu2plNV1q2pblS6VSoT0SgcRoafae-5nrfQbNcL0_CEfjXkiICoMeC9buz18qeI5TZvK9dP5QymFq8et11plx2bgg9Lcvs2TWI3JhIhNsukiNkQxoDrMwlY60OIsE0BBvrZF00py98exTtFRwkIm9dnqLXadFCb7D5e66DjcHvfDcMt9NbnKE-HEWVvlAcEJ77DQofQjAs2A0ziMInTQBSbMCR1OGFx4g8HTh6k2IlczBl1uCDtx7GH3cDpU05THFLI43mWXiDsUU58GbY42qtjxLL9YdRLdDBfzKsrhPVCKQrQ-rM2McAxTYpCfTHGouhrjHs9w-qi7p9irv9Ze0Btn4eD0SCIPm7QSVPa7ClgvW_RQb3aVHfgk-vyvtHmN7iEiQw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=SYNERGETIC+PHARMACEUTICAL+COMPOSITION+FOR+PROPHYLAXIS+AND+TREATMENT+OF+DIABETES+MELLITUS&rft.inventor=SIL%27VASHI+ZOL%27TAN&rft.inventor=LITERATI+NAD%27+PETER&rft.inventor=RABLOTSKI+D%27ERDI&rft.date=2007-12-10&rft.externalDBID=C2&rft.externalDocID=RU2311907C2 |